Kat Kwiatkowski

Kat is responsible for Clinical Operations at Strata, including oversight of the Strata Trial, integration with pharma partnered studies, and clinical development of Strata-sponsored studies. She has extensive regulated product development experience in both drug and diagnostics.

Prior to joining Strata, Kat worked in various Clinical Development roles with increasing responsibilities at Biodesix, Affymetrix, and Eli Lilly & Company.

Kat has an MPH from Indiana University.